The Long Read / Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be considered only a middling-size…
Louis Haynes |
Editor
Louis is the Senior Analyst and Editor-in-Chief. Having directed pharmaceuticals & life science projects across 4 continents, he has published over 30 country reports as well as produced analytical studies on trends in blockchain, Pharma M&A and biotechnology. He has a professional background in consultancy and international business and possesses an MPhil from the University of Oxford and more...
Articles: Louis Haynes
MEA / The Moroccan Firms Bringing MNCs to Africa
Some of the more entrepreneurial Moroccan local laboratories have spotted an opening to leverage their knowledge of…
The Long Read / The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat…
The Long Read / Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the…
Medtech / The UAE: Early Adopters of Cutting-Edge Solutions
In some respects, is it perhaps the medtech sector that has most to be excited about in the UAE’s domestic…
Early Access / The UAE as an Initial Product Launch Platform
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the…
Life Sciences’ Growing Demand for AI Assets
Digital health deal values in biopharma jumped to USD 6.4 billion in 2019, largely thanks to software company…
Challenges to AI in Life Sciences
With so many wild predictions being bandied around about AI’s potential to radically transform healthcare for the…
Rethinking Healthcare Provision with AI
As data and information proliferate at an exponential pace, many industries have turned to artificial intelligence…
De-risking Drug Discovery with AI
On the supply side, AI appears to herald the prospect of de-risking the drug discovery process and doing away with…
Demystifying AI
The AI in Life Sciences Market was valued at USD 902.1 million in 2019 by Mordor Intelligence and is projected to…
Outsourced Manufacturing / A Swiss Specialty
Unknown to some, Switzerland meanwhile remains both influential and relevant in global pharma circles not just for…